Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy.

Zhang, Le; Hou, Ningning; Chen, Bing; Kan, Chengxia; Han, Fang; Zhang, Jingwen; Sun, Xiaodong

Zhang, Le; Hou, Ningning; Chen, Bing; Kan, Chengxia; Han, Fang; Zhang, Jingwen; Sun, Xiaodong.

Afiliação

Zhang L; Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
Hou N; Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, China.
Chen B; Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
Kan C; Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, China.
Han F; Department of Pathology, Affiliated Hospital of Weifang Medical University, Weifang, China.
Zhang J; Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
Sun X; Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, China.

Front Pharmacol ; 13: 908772, 2022.

Article em En | MEDLINE | ID: mdl-35685623

Palavras-chave

cancer; cancer therapy; ferroptosis; p53; pharmacology; post-translational modifications

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google